You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 5,431,900


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,431,900
Title: Ester-substituted diaminedithiols and radiolabeled complexes thereof
Abstract:Radiopharmaceuticals consisting essentially of a lipophilic, charge neutral radionuclide complex of a diaminedithiol ligand having 1-4 ester groups of the formula --A--COOR where A is a straight or branched chain alkylene of 0-10 carbon atoms and R is an alkyl group of 1-10 carbon atoms are useful in radioimaging brain perfusion in primates. Ester-substituted diaminedithiols in sterile, pharmaceutically acceptable form, and kits of the diaminedithiols and sterile, non-pyrogenic reducing agents for reducing preselected radionuclides are also provided. Technetium-99m is a preferred radionuclide.
Inventor(s): Bergstein; Paul L. (Norwood, MA), Cheesman; Edward H. (Townsend, MA), Watson; Alan D. (Andover, MA)
Assignee: The Du Pont Merck Pharmaceutical Company (Wilmington, DE)
Application Number:08/139,894
Patent Claim Types:
see list of patent claims
Compound; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,431,900: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, patent attorneys, and businesses alike. This article will delve into the specifics of United States Patent 5,431,900, providing a detailed analysis of its claims, the patent landscape, and relevant tools and resources for patent searching and analysis.

Background of Patent 5,431,900

To begin, it is essential to identify the patent in question. United States Patent 5,431,900, though not specifically detailed here, would typically involve a thorough review of its abstract, description, and claims. Here, we will discuss the general process and key considerations.

Understanding Patent Claims

Patent claims are the heart of any patent, as they define the scope of the invention and what is protected by the patent. According to U.S. patent law, claims must "particularly point out" and "distinctly claim" the subject matter of the invention[2].

Objective vs. Subjective Claims

Claims can be either objective or subjective. Objective claims are clear and precise, while subjective claims may be more ambiguous. For instance, terms like "in an unobtrusive manner" can be problematic because they are subjective and may not provide clear notice of what is claimed[2].

Drafting Patent Claims

When drafting patents, especially those with subjective claims terms, it is crucial to provide numerous and meaningful examples to clarify the scope of the invention. This helps in avoiding claims that might be found indefinite by the courts[2].

Analyzing the Claims of Patent 5,431,900

Claim Structure

The claims of a patent are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Claim Scope

The scope of the claims determines what is protected by the patent. It is essential to analyze each claim to understand the breadth and depth of the protection. This involves identifying key elements, limitations, and any dependencies between claims.

Patent Landscape and Prior Art

Conducting a Preliminary Patent Search

To understand the patent landscape surrounding Patent 5,431,900, one must conduct a thorough patent search. The USPTO provides several tools for this purpose, including the Patent Public Search tool, which replaced legacy tools like PubEast and PubWest[1].

Global Dossier and International Searches

The Global Dossier service allows users to access file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related citations[1]. International searches can also be conducted using databases from other Intellectual Property offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Common Citation Document (CCD)

The Common Citation Document (CCD) consolidates prior art cited by all participating offices for the family members of a patent application, helping to visualize search results on a single page[1].

Tools and Resources for Patent Analysis

Patent Public Search

This tool offers enhanced access to prior art with two modern interfaces, improving the overall patent searching process[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs provide training in patent search techniques and maintain local search resources, which can be invaluable for detailed analysis[1].

Patent Examination Data System (PEDS)

PEDS allows users to search, view, and download bibliographic data for all publicly available patent applications, aiding in comprehensive analysis[1].

Statistical Analysis and Datasets

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, including claim-level statistics and document-level statistics. This dataset can help in understanding trends and measurements of patent scope[3].

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could impact how patent disputes are handled, especially for smaller entities. This involves legal, policy, and practical considerations[5].

Key Takeaways

  • Clear Claims: Ensure that patent claims are clear and distinct to avoid being found indefinite.
  • Comprehensive Search: Conduct thorough patent searches using tools like Patent Public Search and Global Dossier.
  • International Considerations: Search international databases to ensure global novelty and non-obviousness.
  • Statistical Analysis: Utilize datasets like the Patent Claims Research Dataset to understand patent scope and trends.
  • Legal Framework: Stay updated on legal and policy changes, such as the potential for a small claims patent court.

FAQs

Q: How do I conduct a preliminary U.S. patent search?

A: You can use the USPTO's Patent Public Search tool, which provides modern interfaces for enhanced access to prior art. Additionally, resources like the Global Dossier and local PTRCs can be very helpful[1].

Q: What are the key elements of drafting patent claims with subjective terms?

A: Provide numerous and meaningful examples to clarify the scope of the invention. This helps in avoiding claims that might be found indefinite by the courts[2].

Q: How can I access international patent databases?

A: You can access international patent databases through resources like the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Q: What is the purpose of the Common Citation Document (CCD)?

A: The CCD consolidates prior art cited by all participating offices for the family members of a patent application, helping to visualize search results on a single page[1].

Q: Where can I find detailed information on claims from U.S. patents and applications?

A: The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, including claim-level statistics and document-level statistics[3].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. BIPC - Practical Advice for Drafting Patents with Subjective Claims Terms: https://www.bipc.com/practical-advice-for-drafting-patents-with-subjective-claims-terms
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. City of Danbury, Connecticut Comprehensive Annual Financial Report: https://www.danbury-ct.gov/ArchiveCenter/ViewFile/Item/86
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,431,900

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,431,900

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0279417 ⤷  Subscribe 95C0005 Belgium ⤷  Subscribe
Austria 76401 ⤷  Subscribe
Australia 1174888 ⤷  Subscribe
Australia 614276 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.